Procalcitonin as an effective biomarker for the diagnosis and prognosis of severe sepsis

Drugs of Today

Volumn 41, Issue 4, 2005, Pages 253-256

  Sorbera, Lisa Ann ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CHOLINESTERASE; ENDOTOXIN; FIBRINOGEN; IMMUNOGLOBULIN M; OROSOMUCOID; PMX DHP; POLYMYXIN B; PREALBUMIN; PROCALCITONIN;

ACUTE PANCREATITIS; ADSORPTION; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EFFICACY; EMERGENCY MEDICINE; HORMONE BLOOD LEVEL; HUMAN; INFECTION COMPLICATION; INTENSIVE CARE; LEUKOCYTE COUNT; PANCREAS NECROSIS; PROGNOSIS; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; VENTILATOR ASSOCIATED PNEUMONIA;

BIOLOGICAL MARKERS; CALCITONIN; CLINICAL TRIALS; HUMANS; PROGNOSIS; PROTEIN PRECURSORS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 22244447075     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2005.41.4.900160     Document Type: Conference Paper

References (13)

1. Russwurm, S., Reinhart, K. Procalcitonin mode of action: New pieces in a complex puzzle. Grit Care Med 2004, 32: 1801-2.
2. Simon, L., Gauvin, F., Amre, D.K. et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004, 39: 206-17.
3. Becker, K.L., Nylén, E.S., White, U.C. et al. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004, 89: 1512-25.
4. Meisner, M., Brunkhorst, F.M., Reith, H.B. et al. Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med 2000, 38: 989-95.
5. Foster, D., Romaschin, A., Derzko, A. et al. Rates of agreement of endotoxin, procalcitonin and lactate in septic and non-septic critically ill patients. Critical Care 2005, 9 (Suppl. 1): Abst. P162.
6. Virtzilli, S., Zervakis, D., Koronaios, A. et al. Evaluation of procalcitonin as a diagnostic and prognostic marker in patients with sepsis, severe sepsis and septic shock associated with ventilator-associated pneumonia. Critical Care 2005, 9 (Suppl. 1): Abst. P164.
7. Kazda, A., Valenta, J., Brodska, H. et al. Procalcitonin in the critically ill. Critical Care 2005, 9 (Suppl. 1): Abst. P172.
8. Ikeda, T., Ikeda, K., Nagura, M. et al. Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy. Critical Care 2005, 9 (Suppl. 1): Abst. P165.
9. Gelfand, B., Filimoniv, M., Burnevich, S. et al. The procalcitonin test in the evaluation of clinical severity in patients with acute pancreatitis. Critical Care 2005, 9 (Suppl. 1): Abst. P171.
10. Iasonidou, C., Vasiliadou, G., Ampatzidou, F. et al. The prognostic value of procalcitonin in cardiac surgical patients. Critical Care 2005, 9 (Suppl. 1): Abst. P170.
11. Beloborodova, N., Popv, D., Schatalov, K. et al. Prevention of postoperative infectious complications with procalcitonin-controlled early post-operative administration of IgM-enriched immunoglobulin preparation in high-risk children with congenital heart diseases. Critical Care 2005, 9 (Suppl. 1): Abst. P163.
12. Kalay, F., Bicer, Y., Simsek, S. et al. Does cardiopulmonary bypass affect the procalcitonin level? Critical Care 2005, 9 (Suppl. 1): Abst. P169.
13. Christ-Crain, M., Stolz, D., Bingisser, R. et al. Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: The "ProCAP" study. Critical Care 2005, 9 (Suppl. 1): Abst. P166.